These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9631939)

  • 21. The kinetics of dissolution of calcium oxalate hydrates. II. The dihydrate.
    Tomazic B; Nancollas GH
    Invest Urol; 1980 Sep; 18(2):97-101. PubMed ID: 7410038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth and characterization of calcium oxalate dihydrate crystals (weddellite).
    Lepage L; Tawashi R
    J Pharm Sci; 1982 Sep; 71(9):1059-62. PubMed ID: 7131277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in calcium oxalate crystal, morphology as a function of concentration.
    Burns JR; Finlayson B
    Invest Urol; 1980 Sep; 18(2):174-7. PubMed ID: 7410034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. On the catalysis of calcium oxalate dihydrate formation by osteopontin peptides.
    Chan BP; Vincent K; Lajoie GA; Goldberg HA; Grohe B; Hunter GK
    Colloids Surf B Biointerfaces; 2012 Aug; 96():22-8. PubMed ID: 22503630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition by citrate of spontaneous precipitation of calcium oxalate in vitro.
    Nicar MJ; Hill K; Pak CY
    J Bone Miner Res; 1987 Jun; 2(3):215-20. PubMed ID: 3455168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory effect of pyrophosphate, citrate, magnesium and chondroitin sulphate in calcium oxalate urolithiasis.
    Grases F; Genestar C; Conte A; March P; Costa-Bauzá A
    Br J Urol; 1989 Sep; 64(3):235-7. PubMed ID: 2553195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of trace metals on the inhibition of calcium oxalate crystallization.
    Muñoz JA; Valiente M
    Urol Res; 2005 Aug; 33(4):267-72. PubMed ID: 15937709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Influence of urinary citrate levels on spontaneous calcium oxalate dihydrate crystalluria].
    Hassani MA; Hennequin C; Lacour B; Daudon M
    Prog Urol; 2005 Sep; 15(4):650-5. PubMed ID: 16459680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A method for studying inhibitory activity in whole urine.
    Ryall RL; Hibberd CM; Marshall VR
    Urol Res; 1985; 13(6):285-9. PubMed ID: 3006313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO; Schmiedl A; Manoharan M
    Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Scanning electron microscopy and molecular modeling of inhibition of calcium oxalate monohydrate crystal growth by citrate and phosphocitrate.
    Wierzbicki A; Sikes CS; Sallis JD; Madura JD; Stevens ED; Martin KL
    Calcif Tissue Int; 1995 Apr; 56(4):297-304. PubMed ID: 7767841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitors of oxalocalcic lithiasis: effects of their interactions on calcium oxalate crystallization.
    Muñoz JA; López-Mesas M; Valiente M
    Urology; 2012 Nov; 80(5):1163.e13-8. PubMed ID: 22748613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surface phase transition of hydrated calcium oxalate crystal in the presence of normal and stone-formers' urine.
    Akbarieh M; Tawashi R
    Scanning Microsc; 1990 Jun; 4(2):387-93; discussion 393-4. PubMed ID: 2402611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in urinary nanocrystallites in calcium oxalate stone formers before and after potassium citrate intake.
    Duan CY; Xia ZY; Zhang GN; Gui BS; Xue JF; Ouyang JM
    Int J Nanomedicine; 2013; 8():909-18. PubMed ID: 23467267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of crystallization of calcium oxalate dihydrate in micellar solutions of anionic surfactants.
    Furedi-Milhofer H; Tunik L; Filipovic-Vincekovic N; Skrtic D; Babic-Ivancic V; Garti N
    Scanning Microsc; 1995; 9(4):1061-69; discussion 1069-70. PubMed ID: 8819887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chemical structure of dicarboxylic acids and their capacity inhibiting of calcium oxalate crystal growth].
    Deng SP; Hu P; Ouyang JM
    Guang Pu Xue Yu Guang Pu Fen Xi; 2007 Oct; 27(10):1981-4. PubMed ID: 18306777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of citrate on the different phases of calcium oxalate crystallization.
    Tiselius HG; Berg C; Fornander AM; Nilsson MA
    Scanning Microsc; 1993 Mar; 7(1):381-9; discussion 389-90. PubMed ID: 8316807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Control of calcium oxalate crystal structure and cell adherence by urinary macromolecules.
    Wesson JA; Worcester EM; Wiessner JH; Mandel NS; Kleinman JG
    Kidney Int; 1998 Apr; 53(4):952-7. PubMed ID: 9551403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of urate on calcium oxalate crystallization in human urine: evidence for a promotory role of hyperuricosuria in urolithiasis.
    Grover PK; Ryall RL; Marshall VR
    Clin Sci (Lond); 1990 Jul; 79(1):9-15. PubMed ID: 2167797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A model system for the investigation of urinary stone formation.
    Bouropoulos N; Bouropoulos C; Klepetsanis PG; Melekos M; Barbalias G; Koutsoukos PG
    Br J Urol; 1996 Aug; 78(2):169-75. PubMed ID: 8813906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.